Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -183.39% | 1.45% | -1,549.69% | 109.24% | 48.28% |
| Total Depreciation and Amortization | -73.84% | 190.10% | 1.00% | -0.14% | 0.87% |
| Total Amortization of Deferred Charges | 3.58% | -0.93% | -2.61% | 3.70% | -19.66% |
| Total Other Non-Cash Items | 198.65% | 30.52% | 20.95% | -51.79% | -2.61% |
| Change in Net Operating Assets | 49.10% | -552.51% | 73.31% | 32.19% | -164.30% |
| Cash from Operations | 117.40% | -240.50% | -12.83% | 336.28% | -94.51% |
| Capital Expenditure | -609.26% | 114.87% | -48.17% | -73.32% | -11.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -22.99% | -30.27% | 37.57% | -- |
| Cash from Investing | 34.31% | -1.02% | -45.70% | -39.14% | -60.81% |
| Total Debt Issued | 277.29% | -- | -- | -- | -- |
| Total Debt Repaid | -11,914.74% | -- | -- | 100.00% | 99.87% |
| Issuance of Common Stock | -- | -- | 3,740.98% | -94.23% | -68.29% |
| Repurchase of Common Stock | -1,381.61% | 55.20% | -90.11% | 97.46% | -1,418.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.76% | 6.39% | -1.32% | 0.22% | 1.63% |
| Other Financing Activities | -196.56% | 877.43% | 94.36% | -390.27% | 159.96% |
| Cash from Financing | 11.26% | 1,176.18% | 91.29% | -794.67% | 117.64% |
| Foreign Exchange rate Adjustments | 116.91% | -338.71% | -29.17% | 36.84% | -111.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.17% | 601.53% | 89.43% | -1,053.29% | 1,062.63% |